re: Ann: Variation of Takeover Bid, Extension... cant see where it says why they are extending - is it because they haven't had enough acceptances yet?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025